What Researchers Did
Researchers reported on two cases of fatal aluminum phosphide poisoning in Iran, complicated by a condition called methemoglobinemia.
What They Found
Both patients, who had ingested aluminum phosphide, developed high levels of methemoglobin, specifically 40% and 30%. They also experienced hemolysis and low oxygen saturation despite receiving high oxygen. Neither patient responded to standard treatments like ascorbic acid or methylene blue, and both ultimately died.
What This Means for Canadian Patients
While aluminum phosphide poisoning is less common in Canada, this study highlights the severe and often fatal outcomes when methemoglobinemia occurs. For Canadian patients experiencing similar severe poisoning or methemoglobinemia resistant to conventional treatments, the study suggests considering alternative therapies like hyperbaric oxygen therapy or exchange blood transfusion. This could offer a potential avenue for care in critical situations.
Canadian Relevance
No direct Canadian connection identified.
Study Limitations
This study is limited by being a case report of only two patients, which means its findings cannot be widely generalized.